Latest Recruitment News

Page 12 of 41
Prescient Therapeutics has secured European authorization to initiate a Phase 2a clinical trial of its novel cancer drug PTX-100 for relapsed/refractory Cutaneous T-cell Lymphoma, enabling trial site activation in Italy.
Ada Torres
Ada Torres
15 Dec 2025
Cynata Therapeutics has finalised patient enrolment in its pivotal Phase 2 trial of CYP-001 for acute graft versus host disease, setting the stage for critical data due mid-2026.
Ada Torres
Ada Torres
15 Dec 2025
Dimerix has successfully completed recruitment and dosing of 286 adult patients in its Phase 3 ACTION3 trial evaluating DMX-200 for focal segmental glomerulosclerosis (FSGS), advancing toward regulatory discussions with the FDA.
Ada Torres
Ada Torres
15 Dec 2025
Biome Australia has initiated its first human clinical trial for the proprietary probiotic strain Lactobacillus plantarum BMB18, aiming to validate its benefits for digestive and mood-related symptoms.
Ada Torres
Ada Torres
15 Dec 2025
Emyria Limited is scaling up its Perth Empax clinic with increased therapist approvals and treatment rooms, setting the stage for broader national clinical growth next year.
Ada Torres
Ada Torres
11 Dec 2025
Janus Electric Holdings announces the resignation of CEO Ian Campbell, with interim leadership appointed as the company searches for a successor.
Victor Sage
Victor Sage
10 Dec 2025
LTR Pharma has received regulatory clearance from the Therapeutic Goods Administration to commence its Phase II clinical trial of SPONTAN, focusing on men aged 65 and over. Patient recruitment is set to begin early next year, aiming to address a key gap in erectile dysfunction treatment.
Victor Sage
Victor Sage
10 Dec 2025
Meteoric Resources has successfully produced its inaugural batch of Mixed Rare Earth Carbonate at its Caldeira Pilot Plant in Brazil, marking a significant milestone in its rare earths project development.
Maxwell Dee
Maxwell Dee
10 Dec 2025
PWR Holdings has appointed Sharyn Williams as its new CEO and Managing Director, marking a strategic leadership transition while the search for a new CFO is underway.
Victor Sage
Victor Sage
9 Dec 2025
The Agency Group Australia has set a new record by surpassing $1 billion in residential property sales in November 2025, driven by strong market activity and agent productivity across multiple states.
Eva Park
Eva Park
8 Dec 2025
CLINUVEL Pharmaceuticals is significantly expanding its VALLAURIX RD&I Centre in Singapore with a five-year strategic investment, aiming to become a global leader in advanced peptide drug delivery.
Victor Sage
Victor Sage
8 Dec 2025
Telix Pharmaceuticals has dosed the first patient in the randomized expansion phase of its pivotal ProstACT Global Phase 3 trial for TLX591, targeting advanced prostate cancer. The trial is expanding globally, with regulatory submissions underway in the US and Europe.
Ada Torres
Ada Torres
8 Dec 2025